• Return to Headlines

Highest Free Cash Flow Per Share in the Biotechnology Industry Detected in Shares of Biogen Idec (BIIB, UTHR, AMGN, GILD, REGN)

By Shiri Gupta

Below are the three companies in the Biotechnology industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.

Biogen Idec ranks highest with a FCF per share of $17.89. Following is United Therapeutics with a FCF per share of $13.83. Amgen ranks third highest with a FCF per share of $12.86.

Gilead Sciences follows with a FCF per share of $11.89, and Regeneron Pharmaceuticals rounds out the top five with a FCF per share of $9.18.

SmarTrend recommended that subscribers consider buying shares of Regeneron Pharmaceuticals on May 2nd, 2017 as our technology indicated a new Uptrend was in progress when shares hit $397.84. Since that recommendation, shares of Regeneron Pharmaceuticals have risen 20.7%. We continue to monitor Regeneron Pharmaceuticals for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest free cash flow per share Biogen Idec United Therapeutics Amgen Gilead Sciences regeneron pharmaceuticals

Ticker(s): BIIB UTHR AMGN GILD REGN